These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1608475)

  • 61. Carnitine supplementation in uremia.
    Fürst P; Glöggler A; Rössle C
    Adv Exp Med Biol; 1989; 260():69-77. PubMed ID: 2696372
    [No Abstract]   [Full Text] [Related]  

  • 62. Letter: Histidine for treatment of uraemic anaemia.
    Phillips M; Politis-Tsegos C; de Wardener H
    Br Med J; 1974 Mar; 1(5906):517. PubMed ID: 4817174
    [No Abstract]   [Full Text] [Related]  

  • 63. Intravenous iron dose and mortality in hemodialysis patients.
    Goodkin DA; Bailie GR
    Kidney Int; 2015 Jun; 87(6):1261-2. PubMed ID: 26024036
    [No Abstract]   [Full Text] [Related]  

  • 64. The authors reply.
    Weiss G; Kronenberg F
    Kidney Int; 2015 Jun; 87(6):1262. PubMed ID: 26024038
    [No Abstract]   [Full Text] [Related]  

  • 65. Oral adsorbents in the treatment of uraemia: a review.
    Martin I; Courtney JM
    J Med Eng Technol; 1977 Mar; 1(2):92-4, 110. PubMed ID: 853516
    [No Abstract]   [Full Text] [Related]  

  • 66. Carbenicillin in renal failure.
    Gordon DH
    Lancet; 1970 Aug; 2(7669):422. PubMed ID: 4194730
    [No Abstract]   [Full Text] [Related]  

  • 67. Modification of iron toxicity and/or absorption in mice.
    Eickholt TH; White WF
    J Pharm Sci; 1967 Apr; 56(4):534-6. PubMed ID: 6034556
    [No Abstract]   [Full Text] [Related]  

  • 68. [Treatment with low doses of intravenous iron does not modify hemoglobin nor the erythropoietin dosage].
    Fernández-Gallego J; Martín MA; Alonso A; Toledo R
    Nefrologia; 2006; 26(1):143-4. PubMed ID: 16649439
    [No Abstract]   [Full Text] [Related]  

  • 69. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
    Perazella MA
    Am J Kidney Dis; 1995 Dec; 26(6):1000; author reply 1001. PubMed ID: 7503059
    [No Abstract]   [Full Text] [Related]  

  • 70. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
    Sadjadi SA
    Am J Kidney Dis; 1995 Dec; 26(6):1000-1. PubMed ID: 7503060
    [No Abstract]   [Full Text] [Related]  

  • 71. [Iron requirements of hemodialysis patients. Serum ferritin as an indicator].
    Hunderi OH
    Tidsskr Nor Laegeforen; 1986 Apr; 106(9):738-40. PubMed ID: 3705034
    [No Abstract]   [Full Text] [Related]  

  • 72. The importance and use of iron supplementation in uremia.
    Makoff R
    Nephrol News Issues; 1992 Jun; 6(6):14-6, 19. PubMed ID: 1608475
    [No Abstract]   [Full Text] [Related]  

  • 73. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management.
    Van Wyck DB
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):21-4. PubMed ID: 2669082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit.
    Murphy ST; Parfrey PS
    Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):573-8. PubMed ID: 10541220
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.